AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays

2 years ago

Leading Diagnostic Healthcare Company Begins Manufacturing of Ocular Immunoglobulin (IgE), Lactoferrin Tests to Fulfill Orders From Commercialization Partner SAN DIEGO,…

Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses

2 years ago

Sabizabulin inhibited the cell release and cell-to-cell spread of poxvirus in a preclinical study Veru further expands study of sabizabulin…

Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium

2 years ago

Dr. Redkar to discuss importance of HGF/cMET pathway, which can play critical role in origin of several cancersFOSTER CITY, Calif.,…

Inozyme Pharma to Participate at the 22nd Annual Needham Virtual Healthcare Conference

2 years ago

BOSTON, April 11, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical- stage rare disease biopharmaceutical company developing…

Prelude Therapeutics to Present at American Association for Cancer Research 2023 Conference

2 years ago

Eight Abstracts Demonstrate Progress of Prelude’s Differentiated PipelineWILMINGTON, Del., April 11, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD),…

Shockwave Medical Completes Acquisition of Neovasc

2 years ago

SANTA CLARA, CA, April 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Shockwave Medical, Inc. (NASDAQ: SWAV) (“Shockwave”), a pioneer…

Panbela Regains Worldwide Rights to Develop and Commercialize FlynpoviTM in Patients with Familial Adenomatous Polyposis (FAP)

2 years ago

MINNEAPOLIS, April 11, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics…

Intra-Cellular Therapies to Present at the 22nd Annual Needham Virtual Healthcare Conference

2 years ago

NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development…

electroCore Announces Remittance of Annual License Fee from Teijin for Certain Exclusive Rights in Japan

2 years ago

ROCKAWAY, N.J., April 11, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”) (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness…

Cleantech Blue-Zone Technologies Signs Agreement With Respirair Global

2 years ago

Blue-Zone to install its patented anesthetic capture technology in Respirair manufacturing facilityTORONTO, April 11, 2023 (GLOBE NEWSWIRE) -- Blue-Zone Technologies…